Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,16
KB-0,66
PKN103,86103,880,23
Msft511,26511,311,59
Nokia5,775,898-2,31
IBM306,42306,60,55
Mercedes-Benz Group AG59,4559,48-0,38
PFE25,425,41-1,49
14.11.2025 18:13:49
Indexy online
AD Index online
select
AD Index online
 

  • 22.10.2025 14:04:59
JD Health Intl Rg (US Other OTC (Pink Sheets))
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
7,98 -8,80 -0,77 171 000
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.11.2025
Popis společnosti
Obecné informace
Název společnostiJD Health International Inc
Ticker6618
Kmenové akcie:Ordinary Shares
RIC6618.HK
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.06.2025
Počet zaměstnanců k 30.06.2025 4 572
Akcie v oběhu k 29.08.20253 201 475 111
MěnaCNY
Kontaktní informace
Ulice8th Floor, Building C No. 18 Kechuang 11
MěstoBEIJING
PSČ101111
ZeměChina
Kontatní osoba 
Funkce kontaktní osoby 

Business Summary: JD Health International Inc is an investment holding company primarily engaged in the provision of pharmaceutical and healthcare products, internet healthcare, health management and intelligent healthcare solutions. The Company's businesses primarily include retail pharmacy and healthcare services. The retail pharmacy business is primarily engaged in the sales of pharmaceuticals and health products, as well as medical devices through online marketplace and on-demand retail channels. The healthcare services business is primarily engaged in the provision of healthcare services through Internet hospitals and large language models. The Company is also engaged in the provision of online marketing services such as advertising. The Company primarily conducts its businesses in the domestic market.
Financial Summary: BRIEF: For the six months ended 30 June 2025, JD Health International Inc revenues increased 25% to RMB35.29B. Net income increased 27% to RMB2.6B. Revenues reflect Pharmaceutical and Healthcare products segment increase of 23% to RMB29.33B, Marketplace, Advertising and Other services segment increase of 34% to RMB5.96B, Retail Sales - Total increase of 23% to RMB29.33B.
Odvětvová klasifikace
TRBC2012Drug Retailers (NEC)
MGINDUSTRYRetail (Drugs)
MGSECTORServices
NAICSPharmacies and Drug Retailers
NAICSAdvertising Agencies
NAICSOffices of Other Holding Companies
NAICS2007Pharmacies and Drug Stores
NAICS2007Electronic Shopping
NAICS1997Pharmacies and Drug Stores
NAICS1997Electronic Shopping and Mail-Order Houses
SICDrug Stores/proprietary Stores
SICMedical And Hospital Equipment
SICHealth And Allied Services, Nec
SICAdvertising Agencies
SICHolding Companies, Nec



  • Poslední aktualizace: 14.11.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Executive DirectorDong Cao4929.09.2025
Chief Financial OfficerHui Deng3911.05.202311.05.2023
Company SecretaryMing King Chiu48